Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TCEL currently has ZERO operations. I can't believe folks are buying. LOL.
HIFI - It is not a "point of view" - It is FACT. I am not sure why you are stating there are human trials coming up. That is 100% FALSE. Anyone interested can reach Dr. Casey at paddyslimo@kumeu.com and find out for himself. There are currently NO operations. NONE. Saying there is - is a lie. They were thinking about turning it into an environmental company as Dr. Casey is working on a couple of products..but this company has NOTHING to do with cell therapy.
Richie, There is nothing happening here at all. The company currently has zero operations. The CEO was involved with a lawsuit regarding horse doping. He also has another series of businesses in New Zealand - one of which is the limo company. Dr. Casey owns the patent that was PR'd in August NOT TCEL. Anyway, at this time the patent is worthless and there has been no further research on horses. There have been NO human trials and there is no plan to do so.
Patrick Casey CEO wants it understood that the limo company is part of Casey Land Ltd. ... Casey Land Ltd. Is primarily a farming company that also has land assets.
Sorry Hifi - but TCEL does not even own the patent. Dr. Patrick Casey does. This can even be realized by reading the PR. "US Patent was awarded to Patrick Casey and Transplantation Ltd." TCEL was supposed to "license it" but did not. Patrick Casey now runs a series of businesses in New Zealand. One of which is a limo service. Dr. Casey can be reached directly at paddyslimo@kumeu.com
That is not true. I talked to him too. There is NOTHING going on here. TCEL does not even own the patent - Patrick Casey does. Patrick Casey can be reached at paddyslimo@kumeu.com. The CEO now runs a limo company in Kumeu New Zealand. There are NO human trials being done - nor are there any plans to do so. Investors Beware!!
LOL. Lets see! LMAO! :)
LOL!!
Ironridge is a bunch of scamming goons. They don't have a leg to stand on and will soon be in jail.
Listen, in the United States of America you can claim ANYTHING in the court of law. Every single word in my post is FACT. Not painting a "rosy picture". LOL!! I never said it was over. So again, listen, there is ZERO spin on my account. It is all from the COURT TRANSCRIPTION and through discusions with the company.
SVFC!
Actually they paid the note plus interest and the facility fee.
In preliminary hearing the judge made the following statements.
1. Ironridge NEVER notified SVFC they bought the loan from TCA.
2. Ironridge is NOT owed damages.
3. Ironridge is NOT owed Lawyer fees.
4. Ironridge is NOT owed a facility fee.
So SVFC may be getting some money back.
Also it can be PROVEN that through Ironridge's criminal actions SVFC and SVFC shareholders lost millions.
SVFC is persuing criminal justice.
Ironridge scum bags have lied, shorted, and bullied investors FAR too long. I for one will be VERY HAPPY when justice is served and the Ironridge criminals are behind bars!
SVFC! $$$$$$$$$$$
LOL. It has ALREADY been paid.
LOL.
This has NOTHING to do with SVFC assets. Nothing.
It is NOT a foreclosure situation. Ironridge has NO claims on SVFC assets or patent. None. It is a complete fabrication made up by Ironridge. Like we told you yesterday - see the above sticky.
Also, SVFC paid the loan, plus the faclity fee. The only thing Ironridge is trying to get now is law fees paid. In preliminary hearing the judge made the following conclusions:
1. Ironridge NEVER Notified SVFC they bought the loan from TCA.
2. A facility fee is NOT owed to Ironridge.
3. NO damages are owed to Ironridge.
4. NO law fees are owed to Ironridge.
So some of the over 500,00 paid to Ironridge may have to be returned to SVFC.
This case has NOTHING to do with foreclosure, assets or patent. Nothing.
Anyone claiming it does is in violation of the court mandated restraining order that restricts ANY talk of foreclosure ANYWHERE (including internet postings) indefinitely.
Ironridge is a group of scum bag criminals that are ignorant, greedy and ruthless bullies. SVFC would have NEVER worked with these goons. Ironridge's whole angle has been to make bogus claims so they can keep SVFC in court while they lie, short the stock, and bully investors.
Our Chairman of the Board Michael Hershman has started a criminal investigation against Ironridge. Ironridge has caused SVFC and its investors millions. Ironridge could owe SVFC SIGNIFICANT damages.
Ironridge WILL be prosecuted. Look up who Michael Hershman is.... World renowned authority in ethics and corruption. He did intel for the US government.
Ironridge is dead meat!!
Meanwhile, SVFC has the #1 stem cell technology in the world.
These prices are a gift and will not last long!! UP we go - BIG TIME!
SVFC $$$$$$$$
SVFC $$$ Roche Laboratories $$$
The former president of multi-billion dollar Biotech Roche Laboratories - Myron Holubiak - is now with SVFC!!!!
SVFC has the #1 Stem Cell Technology In THE WORLD!!
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
SVFC!
SVFC $$$ Roche Laboratories $$$
The former president of multi-billion dollar Biotech Roche Laboratories - Myron Holubiak - is now with SVFC!!!!
SVFC has the #1 Stem Cell Technology In THE WORLD!!
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
SVFC!
SVFC BUYOUT:
First - we have a history with MERCK. Merck's subsidiary in Germany- Millipore did all the testing to verify that SVFC's Intellicell process is better than all others in THE WORLD. Our process does not use expensive enzymes (enzymes mostly purchased from Roche Laboratories (Liberase) by competitors) and our process is cheaper, faster and more effective. SVFC's Intellicell process yields 10 to 1000 times the cells of competitors. Our process is top in the world. So 1) Merck.
Next: SVFC does NOT use enzymes (purchased from Roche Laboratories) This is a HUGE shift
...not only does SVFC's Intellicell process clear fda's minimal manipulation where others DO NOT but lets take another look at Roche. They sell the enzymes. SVFC does NOT use them....
SVFC process is best.
The FORMER PRESIDENT of Roche Laboratories (Billion Dollar Biotech) is now with SVFC!!!
Myron Holubiak is his name and it spells $$$$$$$$$$
This is why SVFC is making deals for lab placements in hospitals. HUGE BUCKS there. This plan WAS okay'd by FDA. They developed it WITH SVFC.
Buyout of SVFC would allow Roche or Merck or Teva to do this on a very large scale!
That is why I hope it turns into a partnership not buyout. Instead of .75-1.00 a share we would see multiple dollars.
In several years double digit dollars! What is happening is HUGE. I am VERY EXCITED to be on the ground floor of this MIRACULOUS DEVELOPMENT in medicine...SVF treatment.
The fastest growing most revolutionary shift we have seen in medicine in decades!
SVFC labs and SVFC technicians (in the hospital) will process SVF cells for surgeons. SVFC undisputedly has the #1 process in the world. As SVF treatment grows exponentially (the fastest growing sector in medicine) there could be a lab in every hospital across the country.
THIS is why a huge biotech with huge capital is in buyout talks with SVFC. They have the cash to implement such a large scale plan.
Intellicell is going to become a household name!!
SVFC!!
SVFC BUYOUT:
First - we have a history with MERCK. Merck's subsidiary in Germany- Millipore did all the testing to verify that SVFC's Intellicell process is better than all others in THE WORLD. Our process does not use expensive enzymes (enzymes mostly purchased from Roche Laboratories (Liberase) by competitors) and our process is cheaper, faster and more effective. SVFC's Intellicell process yields 10 to 1000 times the cells of competitors. Our process is top in the world. So 1) Merck.
Next: SVFC does NOT use enzymes (purchased from Roche Laboratories) This is a HUGE shift
...not only does SVFC's Intellicell process clear fda's minimal manipulation where others DO NOT but lets take another look at Roche. They sell the enzymes. SVFC does NOT use them....
SVFC process is best.
The FORMER PRESIDENT of Roche Laboratories (Billion Dollar Biotech) is now with SVFC!!!
Myron Holubiak is his name and it spells $$$$$$$$$$
This is why SVFC is making deals for lab placements in hospitals. HUGE BUCKS there. This plan WAS okay'd by FDA. They developed it WITH SVFC.
Buyout of SVFC would allow Roche or Merck or Teva to do this on a very large scale!
That is why I hope it turns into a partnership not buyout. Instead of .75-1.00 a share we would see multiple dollars.
In several years double digit dollars! What is happening is HUGE. I am VERY EXCITED to be on the ground floor of this MIRACULOUS DEVELOPMENT in medicine...SVF treatment.
The fastest growing most revolutionary shift we have seen in medicine in decades!
SVFC labs and SVFC technicians (in the hospital) will process SVF cells for surgeons. SVFC undisputedly has the #1 process in the world. As SVF treatment grows exponentially (the fastest growing sector in medicine) there could be a lab in every hospital across the country.
THIS is why a huge biotech with huge capital is in buyout talks with SVFC. They have the cash to implement such a large scale plan.
Intellicell is going to become a household name!!
SVFC!!
SVFC $$$ Epic OTC Biotech 2014! $$$
#1 stem cell technology in the world.
Buyout talks with 2 major Biotechs
OS less than 400 million
Will make the AMBS run seem like peanuts. (AMBS higher OS Higher debt)
SVFC$$$ will be legendary!! :)
Right now only .0030!!! (AMBS .06+)
50 bagger in January!!
SVFC!!
SVFC $$$ Epic OTC Biotech 2014! $$$
#1 stem cell technology in the world.
Buyout talks with 2 major Biotechs
OS less than 400 million
Will make the AMBS run seem like peanuts. (AMBS higher OS Higher debt)
SVFC$$$ will be legendary!! :)
Right now only .0030!!! (AMBS .06+)
50 bagger in January!!
SVFC!!
SVFC $$ Clinical Trials for MS:
Fred D. Lublin, M.D.
A renowned authority on the treatment of multiple sclerosis. Along with colleagues at the National Multiple Sclerosis Society, his work has redefined the clinical course definitions of MS.
The recipient of largest-ever NIH grant ($40M) to find MS cure.
-Saunders Family Professor of Neurology
- Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
- Mount Sinai School of Medicine, New York
"We have developed successful clinical trial designs that have provided the validated evidence of efficacy (proof of effectiveness) that is critical for moving the field forward. We will leverage our past and current successes into better future therapies for MS. These include the treatment of progressive disease and the development of strategies for repair of the damaged central nervous system (CNS).
"Several late-phase clinical trials aimed at treating progressive forms of MS are currently underway, as is the early-phase testing of stem cells for potential repair of damaged nerves. New initiatives in treating the symptoms of MS have also yielded encouraging results. Overall, the future for improving the lives of individuals with MS has never looked brighter."
SVFC $$ Clinical Trials for MS:
Fred D. Lublin, M.D.
A renowned authority on the treatment of multiple sclerosis. Along with colleagues at the National Multiple Sclerosis Society, his work has redefined the clinical course definitions of MS.
The recipient of largest-ever NIH grant ($40M) to find MS cure.
-Saunders Family Professor of Neurology
- Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
- Mount Sinai School of Medicine, New York
"We have developed successful clinical trial designs that have provided the validated evidence of efficacy (proof of effectiveness) that is critical for moving the field forward. We will leverage our past and current successes into better future therapies for MS. These include the treatment of progressive disease and the development of strategies for repair of the damaged central nervous system (CNS).
"Several late-phase clinical trials aimed at treating progressive forms of MS are currently underway, as is the early-phase testing of stem cells for potential repair of damaged nerves. New initiatives in treating the symptoms of MS have also yielded encouraging results. Overall, the future for improving the lives of individuals with MS has never looked brighter."
SVFC : In-Human Clinical Studies
Osteoarthritis - phase 1 and 2a study
Dr. James Andrews & Prof. Saith Jazrawi (NYU), Dr. John Theodopolous (Mt. Sinai Toronto)
Focus: pain relief and cartilage regeneration using SVF via intravenous and injection. Randomized double-blind dose-controlled study to show safety and primary efficacy.
Multiple Sclerosis - phase 1 and 2a study
Dr. Fred Lublim (Mt. Sinai, NY) recipient of largest-ever NIH grant ($40M) to find MS cure
In planning stages with Dr. Lublim for open label study of moderate to severe MS patients
Non-Healing Diabetic Ulcers - phase 1 and 2a study
Dr. Harold Brem (Winthrop Univ. Hospital NY), one of the foremost wound healing authorities
IntelliCell and Dr. Brem are developing a treatment methodology that may substantially alter
outcomes for subjects facing amputation as the only alternative
Oral Cavity Gum and Bone Regeneration - phase 1 and 2a study
Dr. Nicholas Toscano, Manhattan periodontics specialist
Study based on peer-reviewed SVF article showing restoration of gum tissue and bone mass
Dermal Regeneration - phase 1 and 2a study
Dr. Sydney Coleman (NY) and Dr. Peter Ashby (London), expert plastic surgeon in autologous cellular treatments
Study will focus on the regenerative capability of IntelliCells to address the aesthetic effects of SVF on wrinkles, lines, scarring, and burn conditions in the human skin
CORPORATE COLLABORATIONS
Millipore, a Division of Merck, Germany
accumulation of data and QA of specimens using flow cytometry
Numoda Corporation, Philadelphia
clinical trial accounting as our Clinical Research Organization
SVFC : In-Human Clinical Studies
Osteoarthritis - phase 1 and 2a study
Dr. James Andrews & Prof. Saith Jazrawi (NYU), Dr. John Theodopolous (Mt. Sinai Toronto)
Focus: pain relief and cartilage regeneration using SVF via intravenous and injection. Randomized double-blind dose-controlled study to show safety and primary efficacy.
Multiple Sclerosis - phase 1 and 2a study
Dr. Fred Lublim (Mt. Sinai, NY) recipient of largest-ever NIH grant ($40M) to find MS cure
In planning stages with Dr. Lublim for open label study of moderate to severe MS patients
Non-Healing Diabetic Ulcers - phase 1 and 2a study
Dr. Harold Brem (Winthrop Univ. Hospital NY), one of the foremost wound healing authorities
IntelliCell and Dr. Brem are developing a treatment methodology that may substantially alter
outcomes for subjects facing amputation as the only alternative
Oral Cavity Gum and Bone Regeneration - phase 1 and 2a study
Dr. Nicholas Toscano, Manhattan periodontics specialist
Study based on peer-reviewed SVF article showing restoration of gum tissue and bone mass
Dermal Regeneration - phase 1 and 2a study
Dr. Sydney Coleman (NY) and Dr. Peter Ashby (London), expert plastic surgeon in autologous cellular treatments
Study will focus on the regenerative capability of IntelliCells to address the aesthetic effects of SVF on wrinkles, lines, scarring, and burn conditions in the human skin
CORPORATE COLLABORATIONS
Millipore, a Division of Merck, Germany
accumulation of data and QA of specimens using flow cytometry
Numoda Corporation, Philadelphia
clinical trial accounting as our Clinical Research Organization
Sydney Coleman MD - SVFC Board of Advisors
To study the regenerative potential of adipose tissue, Dr. Coleman is actively involved in research projects to quantify the regenerative ability of fat grafting and stromal vascular fractions in battle injuries.
-Armed Forces Institute of Regenerative Medicine Biomedical Translational Initiative at the University of Pittsburgh Medical Center (UPMC)
*Study to investigate the “use of concentrated endogenous autologous adipose stromal cells in fat grafts for craniofacial trauma” in 20 soldiers; plus another study project to re-treat subjects in five selected cases.
-Co-Investigator with Peter Rubin on four projects funded by the Department of Defense through the Office of the Assistant Secretary of Defense for Health Affairs.
*Controlled study “to investigate the effect of adding stromal vascular fraction into the grafted fat for facial and cranial war injuries.”
*Pilot study on “enriched autologous fat grafting for treating pain at amputation sites.”
According to Dr. Coleman
"There is now evidence that the stem cells or messengers in all fat tissues aid in the repair of tissues by bringing in a new blood supply or by directly affecting damaged or aging structures. As such, your fat is a repair organ for the body, and moving fat into an area of your body can repair diseases and conditions (such as sun damage and scarring). This is the basis of an entirely new approach to medicine and surgery in which your own body can be used to cure diseases and conditions rather than using drugs or invasive procedures."
Dr. Coleman is VERY connected. He is spreading the awareness of Intellicell's Patented process of separating SVF cells:
++Secretary General of the International Society of Plastic Regenerative Surgery (ISPRES) www.ispres.org, and the President of the meeting in Berlin just held June 2013 ispresberlin2013.com
++Co-Chairman of the 5th International Symposium of Fat Injection and Tissue Regeneration at the Fondazione G. Sanvenero Rosselli in Milan September 14, 2013 www.fondazionesanvenero.org/i-corso-140913.html
++Co-Chairman of the Plastic Surgery section of the Cell Society Europe Meeting November 1-2, 2013 www.plastie-aphm.fr
++Co-president of the International Federation for Adipose Therapeutics and Science (IFATS) and of their annual meeting which will be held next in New York City November 21-24, 2013 www.ifats.org
++Co-President of the Fifth International Conference of Regenerative Surgery to be held in Rome December 13-15, 2013 www.regenerativesurgery.it.
++Member of the Regenerative Medicine Task Force of the American Society of Plastic Surgery and on their Research Workgroup as well as on the committee that organized the first ASPS Regenerative Medicine Summit in Miami, March 14-17, 2013 www.plasticsurgery.org/For-Medical-Professionals/Resources-and-Education/Meetings/Regenerative-Medicine-Summit.html.
SVFC $$ Dr. James Andrews: Board of Advisors
Andrews' patients include:
Tom Brady, Brett Farve, Drew Brees, Kevin Smith, Matt Harvey, Michael Jordan, Jack Nicklaus, Emmitt Smith, John Smoltz, Troy Aikman, Charles Barkley, Roger Clemens,, Reggie Bush, Andrei Markov, Bo Jackson, Adrian Peterson, Marcus Lattimore, Robert Griffin III, Ryan Broyles, Rajon Rondo, Mark Sanchez, Michael Morse, Jonny Venters, Nerlens Noel, Rickie Weeks, Sam Bradford, and Brian Cushing, among others.
Quote from Dr. Andrews in ESPN magazine Dec 2012:
For the past three years, however, Andrews has been experimenting with a new strategy. "Stem cells," he says. "What we call biologics. They're on their way, and that will be a transformational event." Very quietly -- "We don't advertise it," Andrews says, "and we don't want to sensationalize it" -- he and his colleagues at clinics in Birmingham, Ala., and Gulf Breeze, Fla., have been performing stem cell injections on professional athletes. He won't name names, but Andrews has mostly employed stem cells in the deteriorated knees of football players, and virtually all of them have reported significant decreases in pain and inflammation. "It's early," he says, "but the results have been remarkable."
Dr. James Andrews: Board of Advisors SVFC
Andrews' patients include:
Tom Brady, Brett Farve, Drew Brees, Kevin Smith, Matt Harvey, Michael Jordan, Jack Nicklaus, Emmitt Smith, John Smoltz, Troy Aikman, Charles Barkley, Roger Clemens,, Reggie Bush, Andrei Markov, Bo Jackson, Adrian Peterson, Marcus Lattimore, Robert Griffin III, Ryan Broyles, Rajon Rondo, Mark Sanchez, Michael Morse, Jonny Venters, Nerlens Noel, Rickie Weeks, Sam Bradford, and Brian Cushing, among others.
Quote from Dr. Andrews in ESPN magazine Dec 2012:
For the past three years, however, Andrews has been experimenting with a new strategy. "Stem cells," he says. "What we call biologics. They're on their way, and that will be a transformational event." Very quietly -- "We don't advertise it," Andrews says, "and we don't want to sensationalize it" -- he and his colleagues at clinics in Birmingham, Ala., and Gulf Breeze, Fla., have been performing stem cell injections on professional athletes. He won't name names, but Andrews has mostly employed stem cells in the deteriorated knees of football players, and virtually all of them have reported significant decreases in pain and inflammation. "It's early," he says, "but the results have been remarkable."
SVFC CEO: Journal Article in JIACD: co-authored by Dr. Victor
$$$$$$$$$$$
Publication in JIACD-The Journal of Implant & Advanced Clinical Dentistry, "A Prospective Pilot Study on the Clinical Application of Stromal Vascular Fraction Stem Cells in the Treatment of Miller Class l and ll Gingival Recession Defects", by Steven Victor, MD.
www.nxtbook.com/nxtbooks/specops/jiacd_201110/#/24
SVFC = Millionaire Maker - It is being called:
"The Internet of Healthcare"
This is where we are folks! The HUGE internet tech explosion that made investors billions. That is what Stem Cell Therapy in Medicine will be! And here we are at the ground floor of the #1 SVF cell processing technology IN THE WORLD!!
SVFC's Dr. Steven Victor was just in Korea at the world renowned Chaum Stem Cell Institute teaching surgeons how to use the Intellicell method. This is HUGE! At the Institute and other places around the world the Cha Station Stem Cell separator is used. SVFC's Intellicell process has been tested by MERCK subsidiary MILLIPORE and was found to be SUPERIOR to ALL competitors:
1) More Potent- Yields 10-1000 times the cells of all competitors.
2) More Effective - It has been determined that a minimum of 50 million cells is needed to be effective for most disease states. Some processes yield as little as 1 million. The Intellicell process yields 1 billion.
3) Faster than all other processes.
4) Cheaper than all other processes. (does not use enzymes which are very expensive)
5) Safer, does not use enzymes.
SVFC is waiting for patent approval in Korea and other International locations.
THIS IS HUGE!!!
Dr. Victor was just at the world renowned Institute in Korea which uses the Cha Station. They are learning the Intellicell Method! WHICH IS HIGHLY SUPERIOR!!!
Intellicell will be the method used at Chaum Stem Cell Institute, in Korea and AROUND THE WORLD!!
THIS is why we are being bought out - (my hope is this turns to partnership because the value is astronomical!)
Check out the numbers:
Market Indications
$15 billion current market for Regenerative Medicine
1.2 million patients to date treated with RM products and therapies
300 private and 50 public companies with $4.7 billion in total market cap
175,000 peer-reviewed publications and 10,000 issued or pending patents
Proliferation of patient advocacy groups demanding shift to Regenerative Medicine.
$1.5 billion in worldwide research funding projected to $14 billion in 10 years
Potential market is LARGELY UNTAPPED
Projected to reach $300 billion by 2020
source: US Department of Health and Human Services
Many are calling it "The Internet of Healthcare"
We are in for some SERIOUS money!! $$$$$$$$$$$$
SVFC!! :)
SVFC = Millionaire Maker - It is being called:
"The Internet of Healthcare"
This is where we are folks! The HUGE internet tech explosion that made investors billions. That is what Stem Cell Therapy in Medicine will be! And here we are at the ground floor of the #1 SVF cell processing technology IN THE WORLD!!
SVFC's Dr. Steven Victor was just in Korea at the world renowned Chaum Stem Cell Institute teaching surgeons how to use the Intellicell method. This is HUGE! At the Institute and other places around the world the Cha Station Stem Cell separator is used. SVFC's Intellicell process has been tested by MERCK subsidiary MILLIPORE and was found to be SUPERIOR to ALL competitors:
1) More Potent- Yields 10-1000 times the cells of all competitors.
2) More Effective - It has been determined that a minimum of 50 million cells is needed to be effective for most disease states. Some processes yield as little as 1 million. The Intellicell process yields 1 billion.
3) Faster than all other processes.
4) Cheaper than all other processes. (does not use enzymes which are very expensive)
5) Safer, does not use enzymes.
SVFC is waiting for patent approval in Korea and other International locations.
THIS IS HUGE!!!
Dr. Victor was just at the world renowned Institute in Korea which uses the Cha Station. They are learning the Intellicell Method! WHICH IS HIGHLY SUPERIOR!!!
Intellicell will be the method used at Chaum Stem Cell Institute, in Korea and AROUND THE WORLD!!
THIS is why we are being bought out - (my hope is this turns to partnership because the value is astronomical!)
Check out the numbers:
Market Indications
$15 billion current market for Regenerative Medicine
1.2 million patients to date treated with RM products and therapies
300 private and 50 public companies with $4.7 billion in total market cap
175,000 peer-reviewed publications and 10,000 issued or pending patents
Proliferation of patient advocacy groups demanding shift to Regenerative Medicine.
$1.5 billion in worldwide research funding projected to $14 billion in 10 years
Potential market is LARGELY UNTAPPED
Projected to reach $300 billion by 2020
source: US Department of Health and Human Services
Many are calling it "The Internet of Healthcare"
We are in for some SERIOUS money!! $$$$$$$$$$$$
SVFC!! :)
SVFC $$ World Renowned Chaum Stem Cell Institute $$
SVFC CEO Dr. Steven Victor just traveled to Korea to the world renowned Chaum Stem Cell Institute where a majority of the world's stem cell research occurs.
Dr. Victor was there teaching the SVFC Intellicell method.
The Chaum institute developed and has been using the Cha System.
Intellicell technology (SVFC) is MUCH BETTER. The Chaum Institute has a HUGE influence around the world.
What I think will happen in Korea is they will start using our tech as soon as the Korean patent is granted. The tech will be licensed to them and from there all the hospitals in Korea will follow suit.
The Chaum Stem Cell Institute implementing and licensing SVFC's technology will send a VERY strong message around the world.
SVFC is at an insane price of .0030 due to criminal manipulations of Ironridge. HUGE DEVELOPMENTS VERY CLOSE!
In the next month MULTIPLE International patents will be granted. Each one granted increases SVFC's value EXPONENTIALLY!
.03-.05 very short term
.10-.15 with international patent news
SVFC $$ World Renowned Chaum Stem Cell Institute $$
SVFC CEO Dr. Steven Victor just traveled to Korea to the world renowned Chaum Stem Cell Institute where a majority of the world's stem cell research occurs.
Dr. Victor was there teaching the SVFC Intellicell method.
The Chaum institute developed and has been using the Cha System.
Intellicell technology (SVFC) is MUCH BETTER. The Chaum Institute has a HUGE influence around the world.
What I think will happen in Korea is they will start using our tech as soon as the Korean patent is granted. The tech will be licensed to them and from there all the hospitals in Korea will follow suit.
The Chaum Stem Cell Institute implementing and licensing SVFC's technology will send a VERY strong message around the world.
SVFC is at an insane price of .0030 due to criminal manipulations of Ironridge. HUGE DEVELOPMENTS VERY CLOSE!
In the next month MULTIPLE International patents will be granted. Each one granted increases SVFC's value EXPONENTIALLY!
.03-.05 very short term
.10-.15 with international patent news
SVFC $$ EPIC Biotech of 2014!! $$
SVFC $$ EPIC Biotech of 2014!! $$
SVFC = Millionaire Maker - It is being called:
"The Internet of Healthcare"
This is where we are folks! The HUGE internet tech explosion that made investors billions. That is what Cell Therapy in Medicine will be! And here we are at the ground floor of the #1 SVF cell processing technology IN THE WORLD!!
Dr. Victor was just in Korea at the world renowned Chaum Stem Cell Institute teaching surgeons how to use the Intellicell method. This is HUGE! This is where most of the world's stem cell research is done. Chaum licensing Intellicell will send a HUGE message around the world.
SVFC's Intellicell process has been tested by MERCK subsidiary MILLIPORE and was found to be SUPERIOR to ALL competitors:
1) More Potent- Yields 10-1000 times the cells of all competitors.
2) More Effective - It has been determined that a minimum of 50 million cells is needed to be effective for most disease states. Some processes yield as little as 1 million. The Intellicell process yields 1 billion.
3) Faster than all other processes.
4) Cheaper than all other processes. (does not use enzymes which are very expensive)
5) Safer, does not use enzymes.
SVFC is waiting for patent approval in Korea and other International locations.
THIS IS HUGE!!!
Dr. Victor was just at the world renowned Institute in Korea which uses the Cha Station. They are learning the Intellicell Method! WHICH IS HIGHLY SUPERIOR!!!
Intellicell will be the method used at Chaum Stem Cell Institute, in Korea and AROUND THE WORLD!!
THIS is why we are being bought out - (my hope is this turns to partnership because the value is astronomical!)
We are in for some SERIOUS money!! $$$$$$$$$$$$
SVFC!! :)
SVFC = Millionaire Maker - It is being called:
"The Internet of Healthcare"
This is where we are folks! The HUGE internet tech explosion that made investors billions. That is what Cell Therapy in Medicine will be! And here we are at the ground floor of the #1 SVF cell processing technology IN THE WORLD!!
Dr. Victor was just in Korea at the world renowned Chaum Stem Cell Institute teaching surgeons how to use the Intellicell method. This is HUGE! This is where most of the world's stem cell research is done. Chaum licensing Intellicell will send a HUGE message around the world.
SVFC's Intellicell process has been tested by MERCK subsidiary MILLIPORE and was found to be SUPERIOR to ALL competitors:
1) More Potent- Yields 10-1000 times the cells of all competitors.
2) More Effective - It has been determined that a minimum of 50 million cells is needed to be effective for most disease states. Some processes yield as little as 1 million. The Intellicell process yields 1 billion.
3) Faster than all other processes.
4) Cheaper than all other processes. (does not use enzymes which are very expensive)
5) Safer, does not use enzymes.
SVFC is waiting for patent approval in Korea and other International locations.
THIS IS HUGE!!!
Dr. Victor was just at the world renowned Institute in Korea which uses the Cha Station. They are learning the Intellicell Method! WHICH IS HIGHLY SUPERIOR!!!
Intellicell will be the method used at Chaum Stem Cell Institute, in Korea and AROUND THE WORLD!!
THIS is why we are being bought out - (my hope is this turns to partnership because the value is astronomical!)
We are in for some SERIOUS money!! $$$$$$$$$$$$
SVFC!! :)
Very simple-
All they had a right to was 500,000 for the loan they bought from TCA -
A loan Ironridge NEVER NOTIFIED SVFC they bought.
SVFC paid the loan.
End of story.
All this other 100% fabrication about patents, assets, liquidation is a complete criminal disgrace by Ironridge.
Those greedy, seedy, ignorant, bully, criminals make my blood boil.
They will be prosecuted under federal RICO laws!
Meanwhile, SVFC has the #1 technology in the #1 fastest growing sector of medicine.
Only up, Up, UP from here!
Back to .05+ with no news.
However HUGE news is coming - patents, contracts, partnership/buyout!!
.15+ will be here VERY quick.
Partnership - .25-.50 minimum.
SVFC!!
Me too!!! :)
They have ZERO claim to SVFC intellectual property. ZERO.
1) SVFC does not need approval. The process is exempt as it is minimally manipulated.
2)Along with the FDA, SVFC developed a plan going forward that SVFC labs will be placed in US hospitals with SVFC techs processing the cells. Every time SVFC processes cells they get paid.
3) Other places around the world do not deal with the FDA. Therefore, the technology will be licensed to various entities.
4) The court case is meaningless at this point beyond Ironridge lying, manipulating and bullying investors. Please see the above sticky for information.
Monkey - I know that is what they have been SAYING -
But the FACT is they never had ANY claim on the patent.. NEVER.
You are stating my point... By you giving credence to this 100% LIE - SCAM - you are perpetrating EXACTLY what Ironridge wants you to.
They NEVER had ANY right to the patent EVER. It is completely INSANE we are even discussing it.
LOL!! Its like me saying ... I drank a coca-cola this morning. I'm going to put up for sale all coca colas assets and patents for sale.
It is a COMPLETE scam by Ironridge that has ZERO validity!
NONE!
And yes SVFC means a lot to me as a patient and investor...but carrying on ABSOLUTE lies is disgusting regardless!
SVFC!